Drug
[18F]F-RESCA-T4
[18F]F-RESCA-T4 is a pharmaceutical drug with 3 clinical trials. Currently 3 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
3(100%)
Phase Distribution
Ph phase_2
1
33%
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Recruiting3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
3
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
recruiting3100%
Recent Activity
3 active trials
Showing 3 of 3
recruitingnot_applicable
Target-specific immunoPET Imaging of Digestive System Carcinoma
NCT06715839
recruitingphase_2
Trop2-targeted immunoPET Imaging of Solid Tumors
NCT06851663
recruitingnot_applicable
Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer
NCT07026110
Clinical Trials (3)
Showing 3 of 3 trials
NCT06715839Not Applicable
Target-specific immunoPET Imaging of Digestive System Carcinoma
NCT06851663Phase 2
Trop2-targeted immunoPET Imaging of Solid Tumors
NCT07026110Not Applicable
Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3